Literature DB >> 10521390

Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.

J Mikkelsson1, M Perola, P Laippala, V Savolainen, J Pajarinen, K Lalu, A Penttilä, P J Karhunen.   

Abstract

Glycoprotein IIIa (GPIIIa) has a key role in the aggregation of thrombocytes, and it also mediates intimal hyperplasia after endothelial injuries; the possible association of the Pl(A1/A2) polymorphism of the gene for GPIIIa with coronary thrombosis and with the progression of coronary artery disease (CAD) is still to be confirmed. Therefore, the association of the Pl(A) polymorphism with the development of coronary atherosclerosis, coronary narrowing, and myocardial infarction (MI) was studied in a prospective, consecutive autopsy series of 300 middle-aged, white Finnish men (33 to 69 years) suffering sudden out-of-hospital or violent death. Coronary atherosclerosis was measured morphometrically and the coronary stenosis percentage determined from a cast rubber model of the coronary tree. We found a significant inverse relation (P=0.01) between the Pl(A2)-positive genotype and coronary artery stenosis. The frequency of possessing the Pl(A2) allele was significantly (odds ratio [OR] 0.45, 95% confidence interval [CI] 0.22 to 0.98) lower among men with >50% coronary stenosis (18.3%) than among those with <25% stenosis (32.9%). Although the Pl(A) polymorphism was not directly associated with MI, the Pl(A2) allele was present in 11 of the 22 men (50%) with MI and coronary thrombosis (OR 6.6, 95% CI 2.1 to 22.8) but in only 6 of the 47 (12.8%) with MI associated with severe stenosis in the absence of thrombosis. In line with this result, men possessing the Pl(A2) allele also had a larger area of fissured and ulcerated complicated lesions in their coronary arteries (P<0.05). The present results suggest that the Pl(A) polymorphism is involved in the development of CAD and MI. Men with the Pl(A2) allele may harbor more thin-walled, vulnerable coronary plaques, plaques prone to rupture, leading to massive, fatal thrombosis. In contrast, men homozygous for the Pl(A1) allele may more often show stable plaques and present with infarction caused by progressive coronary stenosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521390     DOI: 10.1161/01.atv.19.10.2573

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  The Pl(A2) allele and cardiovascular disease: the pro(33) and con.

Authors:  T V Byzova; E F Plow
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  Comparative pharmacology of GP IIb/IIIa antagonists.

Authors:  Karsten Schrör; Artur-Aron Weber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

Review 3.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

4.  The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used.

Authors:  Katriina Aalto-Setälä; Pekka J Karhunen; Jussi Mikkelsson; Kari Niemelä
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

5.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

6.  Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke.

Authors:  Blanca Elsa Rivera-García; Juan Carlos Esparza-García; Jose Luis Aceves-Chimal; Alfredo Leaños-Miranda; Abraham Majluf-Cruz; Irma Isordia-Salas
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

7.  Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anna M Kucharska-Newton; Keri L Monda; Stephen Campbell; Patrick T Bradshaw; Lynne E Wagenknecht; Eric Boerwinkle; Bruce A Wasserman; Gerardo Heiss
Journal:  Atherosclerosis       Date:  2011-02-02       Impact factor: 5.162

8.  Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study.

Authors:  T A Kunnas; P Laippala; A Penttilä; T Lehtimäki; P J Karhunen
Journal:  BMJ       Date:  2000-07-29

9.  Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men.

Authors:  Minna Pellikka; Lassi Narhi; Markus Perola; Antti Penttila; Pekka J Karhunen; Jussi Mikkelsson
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

10.  Common rs5918 (PlA1/A2) polymorphism in the ITGB3 gene and risk of coronary artery disease.

Authors:  Mehri Khatami; Mohammad Mehdi Heidari; Sorour Soheilyfar
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.